Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18,803 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Immunogenicity of Enterovirus 71 Vaccine (Vero Cell) Administered Simultaneously with Trivalent Split-Virion Influenza Vaccine in Infants Aged 6-7 Months: A Phase 4, Randomized, Controlled Trial.
Xiao Y, Guo X, Zhang M, Chen Y, Zhang Y, Yu X, Luo L, Chen H, Xu W, Liu H, Wu L, Hou R, Ma Y, Long L, Ruan J, Chen W, Yang X. Xiao Y, et al. Vaccines (Basel). 2023 Apr 18;11(4):862. doi: 10.3390/vaccines11040862. Vaccines (Basel). 2023. PMID: 37112774 Free PMC article.
Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: A randomized, controlled, open-label, phase IV clinical trial in China.
Yan S, Chen H, Zhang Z, Chang S, Xiao Y, Luo L, Zhang Z, Sun L, Chen X, Yang Y, Shi X, Guo Y, Sun Y, Li H, Li N, Han S, Ma M, Yang X. Yan S, et al. Among authors: xiao y. Vaccine. 2020 Sep 11;38(40):6274-6279. doi: 10.1016/j.vaccine.2020.07.042. Epub 2020 Jul 31. Vaccine. 2020. PMID: 32747216 Clinical Trial.
Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously with Hepatitis B Virus Vaccine, Group A Meningococcal Polysaccharide Vaccine, Measles-Rubella Combined Vaccine and Japanese Encephalitis Vaccine: A Multi-Center, Randomized, Controlled Clinical Trial in China.
Liu X, Chang S, Wang R, Xiao Y, Li F, Xu Q, Zhang S, Chen X, Zhang S, Zhang M, Chen X, Cao Q, Liu X, Wang H, Zhan D, Chen H, Chen W, Jiang J, Zhang C, Wang H, Gao L, Shi X, Yang X, Xu A. Liu X, et al. Among authors: xiao y. Vaccines (Basel). 2022 Jun 2;10(6):895. doi: 10.3390/vaccines10060895. Vaccines (Basel). 2022. PMID: 35746502 Free PMC article.
Evaluation of Immunogenicity and Safety of Vero Cell-Derived Inactivated COVID-19 Vaccine in Older Patients with Hypertension and Diabetes Mellitus.
Zhang Y, Chen H, Lv J, Huang T, Zhang R, Zhang D, Luo L, Wei S, Liu X, Zhang S, Mu Q, Huang R, Huang J, Xiao Y, Yang Y, Han Y, Gong H, Guan Q, Xie F, Wang H, Li L, Yang X. Zhang Y, et al. Among authors: xiao y. Vaccines (Basel). 2022 Jun 25;10(7):1020. doi: 10.3390/vaccines10071020. Vaccines (Basel). 2022. PMID: 35891184 Free PMC article.
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial.
Chen H, Huang Z, Chang S, Hu M, Lu Q, Zhang Y, Wang H, Xiao Y, Wang H, Ge Y, Zou Y, Cui F, Han S, Zhang M, Wang S, Zhu X, Zhang B, Li Z, Ren J, Chen X, Ma R, Zhang L, Guo X, Luo L, Sun X, Yang X. Chen H, et al. Among authors: xiao y. Vaccine. 2022 Aug 26;40(36):5322-5332. doi: 10.1016/j.vaccine.2022.07.033. Epub 2022 Jul 29. Vaccine. 2022. PMID: 35931636 Free PMC article. Clinical Trial.
Immunogenicity and safety of concomitant administration of the chinese inactivated poliovirus vaccine with the diphtheria-tetanus-acellular pertussis (DTaP) vaccine in children: A multicenter, randomized, non-inferiority, controlled trial.
Sun X, Xu Y, Tang F, Xiao Y, Wang Z, Wang B, Zhu X, Yang X, Chen H. Sun X, et al. Among authors: xiao y. Front Immunol. 2022 Jul 26;13:905634. doi: 10.3389/fimmu.2022.905634. eCollection 2022. Front Immunol. 2022. PMID: 35958596 Free PMC article. Clinical Trial.
Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China.
Chen Y, Xiao Y, Ye Y, Jiang F, He H, Luo L, Chen H, Shi L, Mu Q, Chen W, Guo X, Zhang M, Li J, Guan Q, Chen Z, Yang X. Chen Y, et al. Among authors: xiao y. Front Immunol. 2022 Dec 8;13:1080408. doi: 10.3389/fimmu.2022.1080408. eCollection 2022. Front Immunol. 2022. PMID: 36569946 Free PMC article. Clinical Trial.
Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China.
Tang X, Xiao Y, Deng X, Zhou Y, Chen H, Yan R, Zhu Y, Wang S, Wang H, Zhu X, Luo L, Liu Y, Yin Z, Zhang G, Chen Z, Jiang J, Yang X, He H. Tang X, et al. Among authors: xiao y. Lancet Reg Health West Pac. 2023 Mar 17;34:100725. doi: 10.1016/j.lanwpc.2023.100725. eCollection 2023 May. Lancet Reg Health West Pac. 2023. PMID: 37283972 Free PMC article.
18,803 results
You have reached the last available page of results. Please see the User Guide for more information.